The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduc ...

Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...

Epidermal growth factor receptor (EGFR) is a major driver of cancer dissemination and target for anti-cancer therapies but ...

Discover the unexpected health benefits of diabetes and weight loss medications like Ozempic and Wegovy. Find out how these ...

Some London hospitals that have had redevelopment plans delayed have warned they may have to close their sites before they ...

Whole Foods founder John Mackey stopped drinking in January 2022 after tracking his sleep on his Apple Watch. He said he's ...

Family estrangements occur when at least one family member begins distancing themselves from another because of longstanding negativity in their relationship. While parents say they love their ...

Brenda Herback, 65, is struggling to get rehabilitation support after contracting a serious case of listeria meningitis, a food-borne bacterial illness. Once healthy and very active, she now suffers ...